rs55812024
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS1
The NM_000051.4(ATM):c.2466+7A>G variant causes a splice region, intron change. The variant allele was found at a frequency of 0.0000854 in 1,605,060 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000051.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.2466+7A>G | splice_region_variant, intron_variant | Intron 16 of 62 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152220Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000352 AC: 88AN: 249904Hom.: 0 AF XY: 0.000348 AC XY: 47AN XY: 135128
GnomAD4 exome AF: 0.0000840 AC: 122AN: 1452722Hom.: 1 Cov.: 29 AF XY: 0.0000871 AC XY: 63AN XY: 723246
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152338Hom.: 1 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74502
ClinVar
Submissions by phenotype
not specified Benign:3
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Variant summary: ATM c.2466+7A>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00032 in 275780 control chromosomes, predominantly at a frequency of 0.0046 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 4.6 fold of the estimated maximal expected allele frequency for a pathogenic variant in ATM causing Breast Cancer phenotype (0.001), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. To our knowledge, no occurrence of c.2466+7A>G in individuals affected with Breast Cancer and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -
- -
Hereditary cancer-predisposing syndrome Benign:2
- -
- -
Ataxia-telangiectasia syndrome Benign:1
- -
ATM-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
The ATM c.2466+7A>G variant was not identified in the literature nor was it identified in the following databases: GeneInsight-COGR, Cosmic, MutDB, or LOVD 3.0. The variant was identified in dbSNP (ID: rs55812024) as "With Benign allele", ClinVar (1x benign, 1x likely benign), and Clinvitae databases. The variant was identified in control databases in 89 of 275780 chromosomes at a frequency of 0.0003 (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include Latino in 3 of 34346 chromosomes (freq: 0.00009) and East Asian in 86 of 18806 chromosomes (freq: 0.005), while the variant was not observed in the African, Other, European, Ashkenazi Jewish, Finnish, or South Asian populations. The variant occurs outside of the splicing consensus sequence and 1 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -
Familial cancer of breast Benign:1
This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at